TOP TIERMARKET NEWSWIRE

News & sentiment

BIOCARDIA INC EQUITY Equity (BCDA) — News & AI sentiment

BIOCARDIA INC EQUITY Equity (BCDA) news roundup. 6 stories aggregated over the last 30 days. Average 30-day sentiment is 57.8/100. Recent insider activity (SEC Form 4, 90-day window): 6 purchases totalling $11K and 0 sales totalling $0 — net buying of $11K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

0

30d stories

6

avg sentiment 57.8/100

Insider net (90d)

$11K

6 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

BCDA news in the last 24 hours, 7 days, 30 days and 90 days

How much BCDA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	BCDA stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	0	—	no coverage
Last 30 days	6	57.8/100	BCDA headlines →
Last 90 days	27	56.3/100	BCDA headlines →

Latest stories on BCDA

BioCardia announces FDA acceptance of Helix pre-submission package

The Fly58 · neutralproduct/pr

Oct 19

BioCardia, Inc. (BCDA) files 8-K

SEC 8-K50 · neutralgeneral

Oct 19

BioCardia Announces FDA Acceptance of De Novo Pre-Submission Package for Helix™ Catheter Marketing Clearance FDA Substantive Review and Meeting Expected this Quarter

GlobeNewswire63 · neutralproduct/pr

Oct 19

BioCardia Announces FDA Acceptance of De Novo Pre-Submission Package for Helix™ Catheter Marketing Clearance FDA Substantive Review and Meeting Expected this Quarter

Business Insider63 · neutralproduct/pr

Oct 19

BioCardia, Inc. (BCDA) files 8-K

SEC 8-K50 · neutralgeneral

Oct 7

BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting

GlobeNewswire63 · neutralproduct/pr

Oct 7

BioCardia, Inc. (BCDA) files 8-K

SEC 8-K50 · neutralgeneral

Oct 1

BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter

Business Insider63 · neutralproduct/pr

Oct 1

BioCardia, Inc. (BCDA) files 8-K

SEC 8-K50 · neutralgeneral

Sep 23

BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission

Business Insider63 · neutralgeneral

Sep 23

BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission

GlobeNewswire63 · neutralgeneral

Sep 23

BioCardia, Inc. (BCDA) files 8-K

SEC 8-K50 · neutralgeneral

Sep 21

BioCardia Highlights Therapeutic Pipeline at Investor Conference

TipRanks56 · neutralproduct/pr

Sep 10

BioCardia, Inc. (BCDA) files 8-K

SEC 8-K50 · neutralgeneral

Sep 10

BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference

Business Insider56 · neutralproduct/pr

Sep 10

BioCardia gets FDA confirmation of Helix meeting minutes

The Fly65 · bullishgeneral

Aug 24

BioCardia Advances Helix Catheter Toward De Novo Approval

TipRanks63 · neutralproduct/pr

Aug 24

BioCardia, Inc. (BCDA) files 8-K

SEC 8-K50 · neutralgeneral

Aug 24

BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-On De Novo Pre-Submission for Approval

Business Insider67 · bullishproduct/pr

Aug 24

BioCardia, Inc. (BCDA) files 8-K

SEC 8-K34 · bearishgeneral

Aug 21

BioCardia (BCDA) Q2 2026 Earnings Call Transcript

The Motley Fool59 · neutralearnings

Aug 19

Biocardia outlines Japan CardiAMP Shonin submission next quarter with approval expected about 12 months later

Seeking Alpha63 · neutralproduct/pr

Aug 13

BioCardia, Inc. (BCDA) Q2 2026 Earnings Call Transcript

Seeking Alpha50 · neutralearnings

Aug 13

BioCardia, Inc. (BCDA) files 8-K

SEC 8-K50 · neutralgeneral

Aug 12

BioCardia GAAP EPS of -$0.13 beats by $0.05

Seeking Alpha56 · neutralearnings

Aug 12

Open BCDA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →